Scarica l'app Stockscreener
8.27
0.24%
-0.02
Dopo l'orario di chiusura:
8.27
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BCRX Giù?
Forum
Previsione
Precedente Chiudi:
$8.29
Aprire:
$8.27
Volume 24 ore:
1.58M
Relative Volume:
0.49
Capitalizzazione di mercato:
$1.74B
Reddito:
$557.51M
Utile/perdita netta:
$-35.71M
Rapporto P/E:
-45.94
EPS:
-0.18
Flusso di cassa netto:
$15.50M
1 W Prestazione:
-2.36%
1M Prestazione:
-5.27%
6M Prestazione:
-0.48%
1 anno Prestazione:
-0.12%
Intervallo 1D:
$8.19
$8.36
Intervallo di 1 settimana:
$8.02
$8.49
Portata 52W:
$6.015
$11.31
Biocryst Pharmaceuticals Inc Stock (BCRX) Company Profile
Nome
Biocryst Pharmaceuticals Inc
Settore
Telefono
919-859-1302
Indirizzo
4505 EMPEROR BOULEVARD, DURHAM, NC
Confronta BCRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BCRX
Biocryst Pharmaceuticals Inc
|
8.27 | 1.74B | 557.51M | -35.71M | 15.50M | -0.18 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Biocryst Pharmaceuticals Inc Stock (BCRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-02-25 | Iniziato | Wedbush | Outperform |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-09-18 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-08-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-07-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-02-22 | Aggiornamento | Needham | Hold → Buy |
| 2022-11-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-08-05 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-04-18 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-04-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-10 | Iniziato | Oppenheimer | Outperform |
| 2021-08-06 | Downgrade | Jefferies | Buy → Hold |
| 2021-08-03 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-03-01 | Iniziato | Cowen | Outperform |
| 2020-09-29 | Ripresa | JP Morgan | Overweight |
| 2020-06-17 | Iniziato | BTIG Research | Neutral |
| 2020-05-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2019-11-15 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-05-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-11-16 | Ripresa | Piper Jaffray | Overweight |
| 2018-08-08 | Ripresa | JP Morgan | Overweight |
| 2018-07-17 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2018-06-22 | Iniziato | Seaport Global Securities | Neutral |
| 2018-01-02 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-12-20 | Iniziato | Barclays | Equal Weight |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2017-09-06 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2017-09-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2017-02-16 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-08-12 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2016-08-04 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2016-02-09 | Reiterato | FBR Capital | Outperform |
| 2016-02-09 | Downgrade | JP Morgan | Overweight → Neutral |
| 2016-02-09 | Downgrade | Needham | Buy → Hold |
Mostra tutto
Biocryst Pharmaceuticals Inc Borsa (BCRX) Ultime notizie
Forecasting BioCryst Pharmaceuticals Inc. price range with options dataQuarterly Market Review & Expert Approved Momentum Trade Ideas - Newser
Understanding BioCryst Pharmaceuticals Inc.’s price movement2025 Institutional Moves & Verified Swing Trading Watchlists - Newser
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
71,400 RSUs and 36,700 Stock Options: BioCryst's Latest Employee Compensation Package Details - Stock Titan
Applying Elliott Wave Theory to BioCryst Pharmaceuticals Inc.Gap Up & Daily Profit Maximizing Trade Tips - Newser
What to do if you’re stuck in BioCryst Pharmaceuticals Inc.Earnings Risk Report & Expert Approved Trade Ideas - Newser
BioCryst Pharmaceuticals Inc. stock prediction for this weekEarnings Growth Summary & AI Driven Stock Movement Reports - Newser
How to read the order book for BioCryst Pharmaceuticals Inc.Trade Analysis Report & Daily Growth Stock Investment Tips - Newser
Is BioCryst Pharmaceuticals Inc. a defensive stockJuly 2025 Analyst Calls & Stock Portfolio Risk Management - khodrobank.com
Fibrodysplasia Ossificans Market to Experience Notable Growth in Forecast Span by 2032, DelveInsight Predicts | Ipsen, Regeneron Pharma, Biocryst - Barchart.com
Will BioCryst Pharmaceuticals Inc. benefit from rising consumer demandMarket Performance Report & Risk Controlled Stock Pick Alerts - khodrobank.com
How to build a custom watchlist for BioCryst Pharmaceuticals Inc.July 2025 Decliners & Expert Verified Stock Movement Alerts - Newser
Will BioCryst Pharmaceuticals Inc. see short term momentumTrade Signal Summary & Long-Term Safe Investment Plans - Newser
BioCryst Pharmaceuticals, Inc. (BCRX) Q2 Revenue Soars 49%, Hits Record $163.4 Million on ORLADEYO Surge - Yahoo Finance
Is BioCryst Pharmaceuticals Inc. affected by consumer sentiment2025 Macro Impact & Low Volatility Stock Recommendations - khodrobank.com
Custom watchlist performance reports with BioCryst Pharmaceuticals Inc.2025 Support & Resistance & Daily Risk Controlled Trade Plans - Newser
Is BioCryst Pharmaceuticals Inc. backed by strong institutional buyingOptions Play & Daily Stock Momentum Reports - khodrobank.com
Is BioCryst Pharmaceuticals Inc. forming bullish engulfing patternsJuly 2025 PreEarnings & Consistent Growth Stock Picks - khodrobank.com
Is BioCryst Pharmaceuticals Inc.’s growth already priced in2025 Market Sentiment & Stock Market Timing Techniques - khodrobank.com
Will BioCryst Pharmaceuticals Inc. outperform its industry peersCEO Change & Weekly High Potential Alerts - khodrobank.com
Is BioCryst Pharmaceuticals Inc. still worth holding after the dipMarket Activity Report & AI Driven Stock Reports - Newser
BioCryst Pharmaceuticals Inc. Inches Above Key Support — Safe to Hold getLinesFromResByArray error: size == 0 - kangso.co.kr
Is a relief rally coming for BioCryst Pharmaceuticals Inc. holdersInsider Selling & Real-Time Stock Movement Alerts - Newser
Published on: 2025-09-01 00:02:12 - Newser
What to do if you’re stuck in BioCryst Pharmaceuticals IncTrade Risk Summary & Long-Term Capital Growth Ideas - Newser
How to track smart money flows in BioCryst Pharmaceuticals Inc.2025 Market Outlook & Reliable Breakout Forecasts - Newser
Leading vs lagging indicators on BioCryst Pharmaceuticals Inc. performanceEarnings Recap Report & Daily Profit Focused Screening - Newser
Will BioCryst Pharmaceuticals Inc. stock benefit from AI tech trendsGDP Growth & Weekly Chart Analysis and Guides - Newser
Best data tools to analyze BioCryst Pharmaceuticals Inc. stock2025 Key Lessons & Step-by-Step Trade Execution Guides - Newser
Published on: 2025-08-31 13:57:41 - Newser
Chart based exit strategy for BioCryst Pharmaceuticals Inc.Market Risk Summary & Technical Confirmation Alerts - Newser
Published on: 2025-08-31 12:26:45 - Newser
Can technical indicators confirm BioCryst Pharmaceuticals Inc.’s reversal2025 Analyst Calls & Weekly Watchlist of Top Performers - Newser
Applying Elliott Wave Theory to BioCryst Pharmaceuticals IncJuly 2025 Patterns & Reliable Volume Spike Alerts - Newser
Is BioCryst Pharmaceuticals Inc. forming a bottoming baseJuly 2025 Reactions & Free High Accuracy Swing Entry Alerts - Newser
Is BioCryst Pharmaceuticals Inc. a candidate for recovery playMarket Movement Recap & Pattern Based Trade Signal System - Newser
Published on: 2025-09-02 01:35:10 - Newser
What MACD and RSI say about BioCryst Pharmaceuticals Inc.Weekly Market Outlook & Daily Profit Focused Screening - Newser
What momentum shifts mean for BioCryst Pharmaceuticals Inc.July 2025 Summary & Free Daily Entry Point Trade Alerts - Newser
Biocryst Pharmaceuticals Inc Azioni (BCRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Biocryst Pharmaceuticals Inc Azioni (BCRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HEGGIE THERESA | Director |
Aug 13 '25 |
Sale |
8.51 |
70,000 |
595,868 |
65,352 |
3.60%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):